Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.61 |
| ▸ | TP53 | P04637 | 3/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.58 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5590272 | 0.98 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2MAPTTP53HSD17B10 | |
| SCHEMBL5590400 | 0.98 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2MAPTTP53HSD17B10 | |
| SCHEMBL9975322 | 0.96 | SMN1; SMN2 (0.67) | ALDH1A1SMN1; SMN2MAPTTP53HSD17B10 | |
| SCHEMBL2254917 | 0.94 | CYP2A6 (0.62) | ALDH1A1SMN1; SMN2MAPTTP53HSD17B10 | |
| SCHEMBL17944660 | 0.94 | CYP2A6 (0.62) | ALDH1A1SMN1; SMN2MAPTTP53HSD17B10 | |
| SCHEMBL19039937 | 0.94 | CYP2A6 (0.62) | ALDH1A1SMN1; SMN2MAPTTP53HSD17B10 | |
| SCHEMBL5032444 | 0.91 | SMN1; SMN2 (0.73) | ALDH1A1SMN1; SMN2MAPTTP53HSD17B10 | |
| SCHEMBL29543568 | 0.91 | SMN1; SMN2 (0.73) | ALDH1A1SMN1; SMN2MAPTTP53HSD17B10 | |
| SCHEMBL23733899 | 0.89 | KDM4E (0.59) | ALDH1A1SMN1; SMN2MAPTTP53HSD17B10 | |
| SCHEMBL19164686 | 0.89 | L3MBTL1 (0.66) | ALDH1A1SMN1; SMN2MAPTTP53HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8362246-B2 | Bispyrimidines for electronic applications | BASF SE (DE) | 2013-01-29 | — | — | US | disclosed |
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | BASF SE (DE) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149904-A1 | BISPYRIMIDINES FOR ELECTRONIC APPLICATIONS | DPYD, TYMP, TYMS | ALDH1A1 717/4885SMN1; SMN2 1303/4885MAPT 1242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.